We retrospectively compared the clinical manifestations, laboratory features, and outcome of cryptococcal meningitis in 44 human immunodeficiency virus (HIV)-positive and 21 HIV-negative patients in Durban, South Africa, and contrasted our findings with those in the developed world. Cryptococcal meningitis was the initial AIDS-defining illness in 84% of patients. Headache, fever, convulsions, neck stiffness, and neurological signs were more common in HIV-positive patients. We detected neurological abnormalities in 50% of the HIV-positive group. Seventeen percent of HIVpositive patients had completely normal CSF indices. HIV-positive patients with cryptococcal meningitis frequently had oral candidiasis and tuberculosis as coexistent illnesses. Prognostic factors identified in the West do not appear to be applicable in Africa. Death during hospitalization was significantly higher in the HIV-positive group. HIV-associated cryptococcal meningitis in Africa is apparently associated with higher rates of neurological complications and death than is such disease in developed countries of the world.
Patients and Methods
Medical records of patients discharged from KEH with a diagnosis of cryptococcal meningitis during the period from January 1991 to December 1994 were reviewed. Records that showed definite evidence of C. neoformans infections by microscopy, culture, or histopathology were analyzed further. The cryptococcal latex agglutination test (Crypto Ag; Meridian Diagnostics, Cincinnati) was performed on all CSF samples at initial presentation. All patients with cryptococcal meningitis were tested for HIV infection and were counseled before and after the test.
Patients were considered to have HIV infection if two ELISAs (Abbott Laboratories, Abbott Park, Illinois; Organon Teknika BV, Boxtel, Holland) were positive and if results were confirmed by western blotting (Genelabs Diagnostics, Singapore). Patients were divided into HIV-positive and HIV-negative groups. The clinical presentation, CSF findings, and outcome of cryptococcal infection in these two groups were compared. Factors that would predict a poor outcome were also evaluated.
Statistical Analysis
The x2 test, Fisher's exact test, and Student's t-test, where appropriate, were used to analyze data in the study. Significance was considered to begin at the 0.05% level.
Results
During the 4-year study period, 65 patients with cryptococcal meningitis were identified, all of whose CSF specimens were culture-positive for C. neoformans. Of these 65 patients, 44 (68%) were HIV-infected. A comparison of the clinical and laboratory findings in the HIV-positive and HIV-negative groups is presented in table 1. Of the 10 HIV-infected patients whose CD4 cell counts were determined, the count was <50/mm3 for four, 50-100/mm3 for two, 101-200/mm3 for one, and 201-300/mm 3 for three.
Associated illnesses were diagnosed in 80% (35) of the 44 HIV-positive patients and only 24% (5) of the 21 HIV-negative patients (P = .00001). In the HIV-infected group, tuberculosis (32%), generalized lymphadenopathy (46%), and oral thrush (46%) were the commonest coexistent conditions diagnosed. The diagnosis for the 14 patients with tuberculosis was established by microscopy for acid-fast bacilli (in 5 cases of pulmonary tuberculosis and 2 of cervical lymphadenopathy) or on the basis of clinical and radiographic evidence (in 3 cases of pulmonary tuberculosis, 3 of miliary tuberculosis, and 1 of pericarditis). Other associated illnesses detected in the HIVpositive group were chronic diarrhea (7%), Kaposi's sarcoma (5%), pancytopenia (5%), recurrent salmonella septicemia (2%), cytomegalovirus retinitis (2%), and seborrheic dermatitis (2%). C. neoformans infection was the initial AIDS-defining illness in 84% of patients, extrapulmonary tuberculosis in 14%, and recurrent salmonella septicemia in 2%. Four patients with cryptococcal meningitis also had extrameningeal cryptococcal infections: three were HIV-negative and presented with subcutaneous masses, and the fourth was HIV-positive and had a cryptococcoma of the lung.
Fifteen HIV-positive and seven HIV-negative patients underwent CT scanning of the head. The indications for CT scanning were one or more of the following: cranial nerve palsies (46%), papilledema (41%), focal signs (23%), convulsions (9%), and abnormal mental status (5%). Excluding cerebral atrophy as an abnormality, CT scans revealed abnormalities in 3 (15%) of the HIV-positive patients: multiple cerebral infarcts in 1, abnormal enhancement in the temporal-parietal area in 1, and incidental calcification consistent with neurocystercicosis in 1.
Of the 5 (71%) abnormal CT scans for HIV-negative patients, 4 revealed obstructive hydrocephalus and 1 revealed a single infarct of the caudate nucleus. Of significance is that 80% (12) of the 15 HIV-positive patients and 29% (2) of the 7 HIV-negative patients who underwent CT had normal CT scans but one or more abnormal neurological findings.
Patients were treated with either amphotericin B (with or without flucytosine) or fluconazole. Unfortunately, records of therapy were poorly kept and therefore could not be analyzed.
Sixty-four percent (28) of the 44 HIV-positive patients and 9% (4) of the 21 HIV-negative patients died while receiving therapy in the hospital (P = .0007). Furthermore, 54% (15) of these 28 HIV-positive patients and 50% (2) of these 4 HIVnegative patients died within the initial 2 weeks of therapy (P = .65).
In an attempt to identify factors that would predict a poor outcome, clinical and CSF parameters were compared between patients who were discharged and those who died in the hospital, among the HIV-positive subjects (table 2).
Discussion
C. neoformans is recognized as the most frequent cause of fungal infection of the CNS in immunocompetent as well w. immunocompromised persons [12, 13] . Of the 65 patients identified with cryptococcal meningitis in the present study, 44 (68%) were HIV-infected. The HIV epidemic in South Africa as reflected by the national AIDS statistics, is on the increase It differs from the epidemic in Western countries in that spreac of the virus is predominantly by the heterosexual route, witt most cases occurring in females [14] .
Not unexpectedly, in the present study there was a stead increase in the number of HIV-associated cases of cryptococca meningitis, with females outnumbering males. This contrasts witl the situation in the West, where HIV disease is predominantl] among homosexual men [3] . HIV affects mainly the young and sexually active. This is borne out, in our study, by the different age distribution of cases of cryptococcal meningitis among HIVinfected and HIV-noninfected patients. Eighty-one percent (17) of the 21 HIV-negative patients in this study did not have an obvious predisposing illness, which is significantly higher than the 50% reported in the pre-AIDS era [1, 15] . C. neoformans infection was found to be the initial AIDSdefining illness in 84% of our patients. In comparing this proportion with reports from the United States, our findings are consistent with those reported by Clark et al. [3] but at variance with other reports [5, 6, 9] . In developed countries, cryptococcal infection in patients with AIDS usually occurs in the setting of profound immunodeficiency in patients with a CD4 cell count of <100/mm3 [4] . Although CD4 cell counts are not routinely determined for HIV-infected patients at our hospital, those for the 10 patients whose counts were available varied between 18/mm3 and 270/mm3 . An unexpected finding was that three patients' CD4 cell counts were >200 mm 3 .
Extrameningeal cryptococcal infections occurred in one (2.3%) of our HIV-positive and three (14.3%) of our HIVnegative patients, which are lower proportions than those reported in the Western literature [1, 3, 4] . The lower detection rate in this series possibly reflects the level of aggression with which our physicians look for extrameningeal manifestations.
Previous reports from the developed world have reviewed the clinical characteristics of HIV-infected patients presenting with C. neoformans infection [1, [3] [4] [5] [6] [7] [8] . Headache, fever, and altered mental status were the most frequent findings reported, which is consistent with the observations made by us. However, in contrast, HIV-infected patients in the present series commonly had abnormal neurological signs [1, 3, 4, [6] [7] [8] . Neck stiffness occurred at presentation in 90% of cases and abnormal mental status in 36%, which are similar proportions to those in the only other published series from Africa [11] . However, cranial nerve palsies and papilledema occurred in a much higher proportion of our patients. We cannot offer an explanation for these unusual findings. The clinical features in the HIV-negative group are consistent with those reported in the Western literature [15, 16] .
In comparing the clinical presentations of HIV-positive and HIV-negative groups, headache, neck stiffness, and neurological signs were more common in HIV-positive patients. This is contrary to the experience of other investigators, who have reported that HIV-infected patients with cryptococcal meningitis have fewer neurological signs, probably as a result of a relatively poor CSF inflammatory response [1, [3] [4] [5] [6] [7] .
There is a scarcity of published information on cranial nerve involvement in HIV-positive patients with cryptococcal meningitis, but it is apparently uncommon [3] [4] [5] 8] . The cranial nerve involvement in our patients is similar to that described by Tjia et al. [16] in their review of cryptococcal meningitis. Visual loss (excluding cytomegalovirus retinitis in one patient) occurred in 7% of HIV-positive and 10% of HIV-negative patients, which contrasts with the incidence of 1% reported by Rex et al. [17] in both such groups.
The low proportion of CT abnormalities among HIV-positive patients in the present study (3 of 15) is consistent with that reported from the West [4, 5, 7] . In contrast, the scans of 71% (5) of the 7 HIV-negative patients who underwent CT were abnormal, with obstructive hydrocephalus being detected in 80% (4 of 5). This possibly reflects the more aggressive inflammatory response in the subarachnoid space in this group.
In keeping with a report from tropical Africa, we also found that tuberculosis and oral candidiasis were the most common opportunistic infections associated with cryptococcal meningitis in HIV-infected patients [10] . Forty-eight percent of these patients had more than one associated illness, and oral candidiasis and tuberculosis were the most frequently encountered combination. Since pulmonary tuberculosis is endemic in Africa, we frequently see an association of this disease with cryptococcal meningitis, unlike reports from the West, where disease due to Pneumocystis carinii is a more frequent coexistent illness [3] [4] [5] .
In HIV-negative patients with cryptococcal meningitis, the CSF cell count and protein and glucose levels are reported to be almost always abnormal [1, 3, 7] , which is confirmed by our finding that all HIV-negative patients had one or more abnormal CSF indices. Our finding that 17% of HIV-positive patients had completely normal CSF indices is similar to that reported by Dismukes [7] but at variance with other reports from the West [1, 6] .
The CSF abnormalities associated with cryptococcal meningitis are nonspecific since similar abnormalities may occur in tuberculous and other chronic meningitides. In areas of the world where tuberculosis is endemic, cryptococcal meningitis is often misdiagnosed as tuberculous meningitis because it is not routine practice to perform the cryptococcal antigen test or India ink staining or to incubate CSF cultures for longer than 48 hours [11] . In the present series, two cases were initially misdiagnosed as tuberculous meningitis but later were revealed to be cryptococcal infection. Repeated lumbar puncture in one of the patients revealed cryptococci, while in the other cryptococcal subcutaneous masses developed during antituberculous therapy.
The India ink stain of CSF from HIV-infected patients in our study was positive for 93%, which is higher than the figure documented in the Western literature but similar to that reported in a study from Africa [1, 3, 4, 6, 9, 11] . The significantly higher positivity rate of the India ink stains and the significantly higher mean cryptococcal antigen titer among the HIV-positive patients reflect the greater fungal load in these patients [1, 3] . We therefore routinely perform these additional tests on all CSF samples from patients with suspected HIV infection.
Abnormal mental status, CSF WBC count of <20/mm 3 , initial high CSF antigen titer of >1:1,024, age of <35 years, extraneural cultures positive for C. neoformans, and CT scan abnormalities have all been recognized as indicators of a poor prognosis [1, 2-4, 6, 8, 9] . In the present study none of these features were found to have value in predicting outcome. Therefore, it appears that prognostic factors identified in the West are probably not applicable in Africa, possibly because of the advanced stage of the illness at the time of presentation.
Cryptococcal meningitis in patients with AIDS is associated with greater morbidity and mortality than in HIV-negative patients [3] . This is borne out by our finding that significantly more HIV-positive patients (64%) than HIV-negative patients (9%) died while receiving therapy in the hospital. Fifty-four percent of the HIV-infected patients died within the first 2 weeks of therapy, which is higher than the 17%-37% reported in other series in developed countries [3] .
In conclusion, our findings indicate that HIV-associated cryptococcal meningitis in Africa is associated with higher rates of neurological complications than that seen in developed countries of the world, possibly because patients present later in the the course of their illness.
